Asosiy kontentga oʻtish
AkademScholar

Kashfiyot

Xizmatlar

Identifikatsiya

Ishlab chiquvchilar uchun

Ekotizim

Muassasalar

University Hospital Heidelberg

Nom variantlari: Universitätsklinikum Heidelberg

Davlat:
DE
ROR:
https://ror.org/013czdx64
7
h-indeks
276
Iqtiboslar
97
Asarlar
384
Mualliflar
Vaqt boʻyicha

Vaqt boʻyicha tahlil

Iqtibos sharhi

Yillar boʻyicha nashrlar (ustun) va iqtiboslar (chiziq)

  • Nashrlar
  • Iqtiboslar
05101520025507510020172018201920202021202220232024202520262017: Nashrlar 7, Iqtiboslar 42018: Nashrlar 7, Iqtiboslar 22019: Nashrlar 8, Iqtiboslar 62020: Nashrlar 12, Iqtiboslar 132021: Nashrlar 11, Iqtiboslar 162022: Nashrlar 5, Iqtiboslar 202023: Nashrlar 1, Iqtiboslar 322024: Nashrlar 4, Iqtiboslar 442025: Nashrlar 4, Iqtiboslar 542026: Nashrlar 8, Iqtiboslar 82

Iqtibos tarixi

025507510020172018201920202021202220232024202520262017: Iqtiboslar 42018: Iqtiboslar 22019: Iqtiboslar 62020: Iqtiboslar 132021: Iqtiboslar 162022: Iqtiboslar 202023: Iqtiboslar 322024: Iqtiboslar 442025: Iqtiboslar 542026: Iqtiboslar 82

Nashr tarixi

0510152020172018201920202021202220232024202520262017: Nashrlar 72018: Nashrlar 72019: Nashrlar 82020: Nashrlar 122021: Nashrlar 112022: Nashrlar 52023: Nashrlar 12024: Nashrlar 42025: Nashrlar 42026: Nashrlar 8

h-indeks evolyutsiyasi

Yillar boʻyicha jamlangan h-indeks

03581020172018201920202021202220232024202520262017: h-indeks 12018: h-indeks 12019: h-indeks 12020: h-indeks 22021: h-indeks 32022: h-indeks 32023: h-indeks 32024: h-indeks 42025: h-indeks 42026: h-indeks 7

Eng koʻp iqtibos qilingan asarlar

  1. Superior biocompatibility and comparable osteoinductive properties: Sodium-reduced fluoride-containing bioactive glass belonging to the CaO–MgO–SiO2 system as a promising alternative to 45S5 bioactive glass20209 iqtibos
  2. Synthesis, Structure–Property Evaluation and Biological Assessment of Supramolecular Assemblies of Bioactive Glass with Glycyrrhizic Acid and Its Monoammonium Salt20224 iqtibos
  3. Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 201720192 iqtibos
  4. Positionspapier zur Zertifizierung von Telemedizinzentren20211 iqtibos
  5. Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 201920211 iqtibos
  6. RETRACTED: Antimicrobial resistance related knowledge, attitude and practice of general practitioners, patients and farmers: A cross-sectional study in Uzbekistan20241 iqtibos
  7. Overweight, obesity, and cardiovascular disease in heterozygous familial hypercholesterolaemia: the EAS FH Studies Collaboration registry20251 iqtibos
  8. Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 201620181 iqtibos
  9. Synthesis of Silver Modified Bioactive Glassy Materials with Antibacterial Properties via Facile and Low-Temperature Route20201 iqtibos
  10. Telemedizinisches Monitoring bei herzinsuffizienten Patienten20050 iqtibos